Skip to main content
CL logo

Colgate-Palmolive Company (CL) Stock: Price, Forecast & Analyst Target

Colgate-Palmolive Company (CL) — MoonshotScore 93/100 (Exceptional band), calculated Nov 18, 2026. Price $98.85 (-0.76%), as of the Nov 18, 2026 trading session; market cap $78.6B. Expected results Jan 29, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$98.85 −$0.76 (-0.76%) Market Cap $78.6B

Colgate-Palmolive Company · CL · NYSE · Consumer Defensive · Household & Personal Products

Research dated 2026-09-12: Colgate-Palmolive sells repeat-purchase oral, personal and home-care products alongside Hill's pet nutrition through retail, dental and veterinary channels. The case hinges on whether steady sales expansion can absorb higher input costs, tariffs and planned brand spending while restoring the conversion of revenue into operating profit.

Price as of Nov 18, 2026

Key Statistics

93 of 100

MoonshotScore v2 · Colgate-Palmolive Company (CL)

Exceptional
Business Quality Elite (99)
Financial Safety Sound (72)
Valuation Rich (24)
Growth Durability Growing (62)
Momentum Rising (79)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality and a strong balance sheet, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Rich; Growth Durability: Growing; Momentum: Rising.

Price relative to book value is the main valuation drag relative to sector peers.

  • quarterly revenue $5.13B (Q3 FY2025, quarter ended Sep 2025)
  • EPS beat 8 of the last 8 reports
  • expected results Jan 29, 2027

Holding back: a rich price

Helping: business quality, balance-sheet strength, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for CL (57 recorded, newest six shown)
RecordedScoreBand
87Exceptional
89Exceptional
89Exceptional
89Exceptional
93Exceptional
93Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$98.85
Change on the day-0.76%
52-week range$75.96–$101.81
Market capitalisation$78.6B—
Price / earnings (trailing)38.70
Shares traded on the day6.07M
Beta (volatility vs the S&P 500)0.31

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $77, high $100, latest $99. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $100 $77 high $100 Jan 30, 2026 · Earnings results · reported above the recorded estimate · close $901May 1, 2026 · Earnings results · reported above the recorded estimate · close $872Jul 31, 2026 · Earnings results · reported above the recorded estimate · close $913Oct 30, 2026 · Earnings results · reported above the recorded estimate · close $954 Oct 17, 2025 Nov 18, 2026 · $99 $79Oct 17, 2025$77Oct 31, 2025$78Nov 14, 2025$80Nov 28, 2025$78Dec 12, 2025$80Dec 26, 2025$81Jan 9, 2026$87Jan 23, 2026$94Feb 6, 2026$95Feb 20, 2026$94Mar 6, 2026$85Mar 20, 2026$85Apr 2, 2026$86Apr 17, 2026$87May 1, 2026$88May 15, 2026$90May 29, 2026$89Jun 12, 2026$92Jun 26, 2026$92Jul 10, 2026$91Jul 24, 2026$93Aug 7, 2026$91Aug 21, 2026$89Sep 4, 2026$87Sep 18, 2026$84Oct 2, 2026$94Oct 16, 2026$95Oct 30, 2026$100Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for Colgate-Palmolive Company (CL): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Moderate
Valuation Weak
Growth Durability Moderate
Momentum Moderate

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 19, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Neutral
Revenue Growth Weak
Debt/Equity Negative
ROE Strong
Gross Margin Strong

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company less favourably than the MoonshotScore does: Griffin-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Colgate-Palmolive Company (CL), and what does it report?

Short answer · as of

Colgate-Palmolive is much more than a toothpaste and soap company.

Its main business spans oral care, personal care and household products, while Hill's sells everyday and therapeutic nutrition for dogs and cats; professional oral-health products add dentists to a distribution network otherwise built around retailers, wholesalers, veterinary clinics and online platforms.

Reported revenue separates Oral, Personal and Home Care from Pet Nutrition. The consumer-care group remains the larger contributor, but the pet business gives the company exposure to animal health needs and veterinary distribution rather than only household shopping patterns.

2 · Latest results

What do the latest results show for Colgate-Palmolive Company (CL)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $5.13B.

Sales advanced again in the latest period, extending an upward annual trajectory. Gross profit also increased, but operating profit pulled back alongside higher selling, general and administrative expense, so the latest top-line gain did not fully reach operating earnings. Net income improved from the preceding period after the unusual loss recorded around the annual close.

Reported earnings have repeatedly exceeded expectations, while revenue has beaten estimates in nearly every recent release. Management attributes the prospective improvement path to new-product execution, closing promotional gaps, greater advertising support and a broader productivity program; those are stated priorities, not yet proof that profit conversion has recovered.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$5.37B Oct 30, 2026
Latest report · revenue estimate
$5.34B Oct 30, 2026
Latest report · revenue vs estimate
Above estimate Oct 30, 2026
Latest report · EPS vs estimate
Above estimate Oct 30, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Oct 30, 2026$5.37B$5.34B$0.9700$0.9260
Jul 31, 2026$5.36B$5.36B$0.9900$0.9470
May 1, 2026$5.32B$5.22B$0.9700$0.9430
Jan 30, 2026$5.23B$5.12B$0.9500$0.9120
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$5.13B$735M$0.91 (diluted)
Q4 FY2025$5.23B-$37M-$0.05 (diluted)
Q1 FY2026$5.32B$646M$0.80 (diluted)
Q2 FY2026$5.36B$693M$0.86 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Colgate-Palmolive Company (CL)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Operating cash flow has exceeded capital spending throughout the reported series, leaving meaningful internally generated funds after investment in the business. Cash has remained within a relatively narrow range and finished only modestly below its opening level, which points to stability rather than a persistent operating drain.

Debt materially exceeds cash and short-term investments. Near-term liquidity appears adequate but not abundant, making sustained cash generation more important than the cash balance alone; strong distress and financial-quality screens provide a counterweight, but they do not remove refinancing or execution risk.

Higher raw-material costs and tariffs could pressure gross profit just as management increases advertising. That combination would hurt if brand support fails to produce enough sales or pricing benefit, especially because annual revenue growth has recently coexisted with uneven net income.

4 · What to check next?

What should you watch next at Colgate-Palmolive Company (CL)?

Short answer · as of

The next earnings report is expected on Jan 29, 2027.

The next release should be judged on the link between sales, gross profit and operating profit rather than revenue alone. Management expects greater raw-material and tariff pressure later in the year while stepping up advertising and addressing promotion gaps and new-product execution. Continued sales progress with stable gross profitability and firmer operating profit would support that plan; weakening gross profit as spending rises would challenge it.

Cost actions also deserve attention. Recent company reporting flagged costs associated with exit or disposal activities, while management tied its longer-term strategy to productivity and organizational structure. The useful test is whether those actions improve profit conversion rather than merely shift expenses.

Analyst forecasts assume revenue and earnings continue rising across the forecast horizon. Upcoming results therefore need to sustain the recent pattern of expectation beats while showing that the operating engine, not only adjusted earnings, is strengthening.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The newest quarter held here (Q3 FY2025) was filed Oct 31, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Colgate-Palmolive Company compare with its peers?

Short answer

Colgate-Palmolive Company's score ranks 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Colgate-Palmolive combines mass-market household staples with a specialized pet-nutrition franchise. Hill's sells everyday food as well as therapeutic diets for health conditions through veterinary clinics, pet retailers and online channels, while the consumer-care portfolio reaches broad retail distribution and dental professionals.

That mix differs from a household-products business dependent solely on supermarket and pharmacy shelves. Pet Nutrition remains the smaller reported segment, yet its veterinary orientation, therapeutic products and dedicated veterinary leadership create a distinct customer and demand structure within the same company.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Inter Parfums, Inc. (IPAR) Same industry, near in market value$133.73 Nov 18, 2026$4.28B96 5-pillar Nov 18, 2026
Colgate-Palmolive Company (CL) — this page$98.85$78.6B93
Unilever PLC (UL) Same industry, near in market value$64.53 Nov 18, 2026$139B88 5-pillar Nov 18, 2026
The Procter & Gamble Company (PG) Same industry, near in market value$170.29 Nov 18, 2026$395B88 5-pillar Nov 18, 2026
e.l.f. Beauty, Inc. (ELF) Same industry, near in market value$113.77 Nov 18, 2026$6.73B84 5-pillar Nov 18, 2026
Church & Dwight Co., Inc. (CHD) Same industry, near in market value$111.86 Nov 18, 2026$26.4B82 5-pillar Nov 18, 2026
Kimberly-Clark Corporation (KMB) Same industry, near in market value$107.24 Nov 18, 2026$65.8B79 5-pillar Nov 18, 2026
Coca-Cola Europacific Partners PLC (CCEP) Named competitor$118.86 Nov 18, 2026$52.1B73 5-pillar Nov 18, 2026
Mondelez International, Inc. (MDLZ) Named competitor$66.56 Nov 18, 2026$84.3B72 5-pillar Nov 18, 2026
Diageo plc (DEO) Named competitor$99.69 Nov 18, 2026$55.5B72 5-pillar Nov 18, 2026
The Kroger Co. (KR) Named competitor$69.05 Nov 18, 2026$40.8B64 5-pillar Nov 18, 2026
The Estée Lauder Companies Inc. (EL) Same industry, near in market value$104.04 Nov 18, 2026$37.7B64 5-pillar Nov 18, 2026
The Clorox Company (CLX) Same industry, near in market value$108.39 Nov 18, 2026$13.1B60 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Consumer Defensive stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$95.00 – $112.00
Consensus target
$101.30
Median target
$102.50

Consensus record · Captured .

Measured against a quoted price of $98.85 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Nov 10, 2026

Transactions
60
Identified insiders
12
Purchases
0
Sales
9
Other transactions
51

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CL in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported CL in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What Investors Ask About Colgate-Palmolive Company (CL) — Consumer Defensive

The last 2 questions are answered from this page's own dated data, not from the research.

What makes Hill's Prescription Diet different from Colgate-Palmolive's household brands?

Hill's Prescription Diet consists of therapeutic foods designed to help manage health conditions in dogs and cats. Veterinary clinics form part of its distribution network, giving the franchise a professional animal-health channel that household cleaners and personal-care products do not share.

Is Colgate-Palmolive still mainly an oral, personal and home-care company?

Oral, Personal and Home Care remains the larger reported business. Hill's Pet Nutrition is nevertheless a substantial separate contributor with different products, customers and routes to market.

Why did Colgate-Palmolive's latest sales growth not produce higher operating profit?

Gross profit rose, but selling, general and administrative expense also climbed and operating profit declined. Management is planning heavier advertising support, making the conversion of brand spending into sales and profit an important test.

Can Colgate-Palmolive fund its brands while carrying more debt than cash?

Current cash generation has covered capital spending with ample room remaining, supporting continued business investment. Debt is still far larger than cash, and liquid-asset coverage is not generous, so that capacity depends on operating cash flow remaining durable.

What is the CL stock price today?

The last price recorded for Colgate-Palmolive Company (CL), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the CL price target?

The analyst consensus price target for Colgate-Palmolive Company (CL), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 43 figures on this page — 36 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Annual revenue and net result (USD millions); Management outlook — dated call excerpts
  • 1. What is Colgate-Palmolive Company (CL), and what does it report?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Named officers
  • 2. What do the latest results show for Colgate-Palmolive Company (CL)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Most recent periodic reports
  • 3. What are the financial strengths and risks for Colgate-Palmolive Company (CL)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Distress and quality screens; Annual revenue and net result (USD millions); Management outlook — dated call excerpts
  • 4. What should you watch next at Colgate-Palmolive Company (CL)?: Next earnings report; Analyst revenue and earnings estimates (average); Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Management outlook — dated call excerpts; Recent SEC filings
  • 5. How does Colgate-Palmolive Company compare with its peers?: Business description; Revenue by segment; Named officers; Sector / industry (provider taxonomy)
  • FAQ: What makes Hill's Prescription Diet different from Colgate-Palmolive's household brands?: Business description; Revenue by segment; Named officers
  • FAQ: Is Colgate-Palmolive still mainly an oral, personal and home-care company?: Revenue by segment; Business description
  • FAQ: Why did Colgate-Palmolive's latest sales growth not produce higher operating profit?: Quarterly income statement (USD thousands); Management outlook — dated call excerpts
  • FAQ: Can Colgate-Palmolive fund its brands while carrying more debt than cash?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash against market value; Trailing twelve-month ratio set
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold CL

Funds in our ETF coverage that list CL among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
FSTA ETF2.38%
ProShares - Russell U.S. Dividend Growers ETF (TMDV)1.77%
ProShares - S&P 500 Dividend Aristocrats ETF (NOBL)1.62%